Title New advances in ILD (February 2020).pptx ✅

Presenter: Dr. Sai Krishna Moderator: Dr. Tabish Mohammad Department Of Medicine AIIMS, New Delhi Preceptors: Prof. Sanjeev Sinha, Dr. Animesh Ray, Department Of Medicine Co-Preceptor: Dr. Surabhi Vyas Department of Radiodiagnosis AIIMS, New Delhi ILD- NEW ADVANCES # 26 Feb, 2020
Interstitial Lung Disease(ILD) (or) Diffuse Parenchymal Lung Disease(DPLD) Heterogeneous group of disorders Classified together because of similar clinical, radiographic and pathological features. Begins in the “interstitium” “misleading to call interstitial lung disease”: leads to extensive alteration of alveolar and airway architecture. Am J Respir Crit Care Med 2013; 188:733. 26 Feb, 2020 #
Classification of ILD Interstitial Lung Diseases Etiology known Etiology unknown Inorganic exposure • Asbestosis • Silicosis • Coal worker Pneumoconiosis Organic exposure • Bird-Fancier’s • Farmer’s lung • Mold • Hot-tub HP Smoking • DIP • RB-ILD • LCH Granulomatous • Sarcoidosis Idiopathic interstitial pneumonias IPF Non-IPF COP LIP AIP NSIP Rare forms of ILD • LAM Connective tissue disease • Rheumatoid arthritis •Polymyositis/dermatomyo sitis • Scleroderma • Sjögren syndrome Drugs/Radiation • Nitrofurantoin • Amiodarone • Methotrexate • Chemotherapy • Radiotherapy 26 Feb, 2020 # AJRCCM, 2013;188(6):733–748. DIP, desquamative interstitial pneumonia; RB-ILD, respiratory bronchiolitis-ILD; LCH, Langerhans cell histiocytosis; LAM, lymph-angio-leiomyomatosis, LIP, lymphocytic interstitial pneumonia; AIP, acute interstitial pneumonia.